/usr/share/refdb/examples/pubmed.xml is in refdb-clients 1.0.2-1.
This file is owned by root:root, with mode 0o644.
The actual contents of the file can be viewed below.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 | <?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2007//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_070101.dtd">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>17311552</PMID>
<DateCreated>
<Year>2007</Year>
<Month>02</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>03</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4316</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2007</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Current pharmaceutical biotechnology</Title>
</Journal>
<ArticleTitle>Development of tissue engineered vascular grafts.</ArticleTitle>
<Pagination>
<MedlinePgn>43-50</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Vascular bypass grafting is a commonly performed procedure for ischemic heart disease and peripheral vascular disease. However, approximately one in fourteen patients do not have suitable autologous arteries or veins available for grafting. Synthetic vascular grafts were introduced in the 1960s to overcome these problems, but while they perform adequately in high-flow, large-diameter vessel settings they are generally not suited to low-flow, small-diameter vessels. Tissue engineering is a relatively new discipline that offers the potential to create replacement structures from autologous cells and biodegradable polymer scaffolds. Because tissue engineering constructs contain living cells, they may have the potential to grow, self-repair, and self-remodel. Therefore, recently there has been much interest in the use of this technique to produce low-flow small-diameter arteries. The latest and most exciting developments in this area involve the use of multipotent stem cells as a cell source for tissue engineering of vascular grafts (both in vivo and in vitro).</AbstractText>
</Abstract>
<Affiliation>Centre for Research in Vascular Biology, Department of Anatomy and Developmental Biology, School of Biomedical Sciences, Otto Hirschfeld Building, Room 513, University of Queensland, Brisbane, Queensland, 4072, Australia. g.campbell@uq.edu.au</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>G R</ForeName>
<Initials>GR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Curr Pharm Biotechnol</MedlineTA>
<NlmUniqueID>100960530</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Bioprosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Blood Vessel Prosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Culture Techniques</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endothelial Cells</DescriptorName>
<QualifierName MajorTopicYN="Y">cytology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Stem Cell Transplantation</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Stem Cells</DescriptorName>
<QualifierName MajorTopicYN="Y">cytology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Engineering</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>107</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17311552</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>17237555</PMID>
<DateCreated>
<Year>2007</Year>
<Month>01</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>03</Month>
<Day>16</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1550-8943</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2006</Year>
</PubDate>
</JournalIssue>
<Title>Stem cell reviews</Title>
</Journal>
<ArticleTitle>Cord-blood mesenchymal stem cells and tissue engineering.</ArticleTitle>
<Pagination>
<MedlinePgn>163-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Institute of Reconstructive Plastic Surgery, Laboratory of Vascular Tissue Engineering and Microvascular Research, New York University, New York, NY and Long Island Plastic Surgical Group, Garden City, NY Cord-blood-derived stem cells have proven clinically useful for numerous disease states, as have mesenchymal stem cells (MSCs) derived from bone marrow and adipose tissue. The recent identification of MSCs in cord-blood heralds cord-blood as an untapped resource for nonhematopoietic stem cell-based therapeutic strategies for the replacement of injured or diseased connective tissue. This review discusses the potential for tissue engineering applications of MSCs, highlighting the development of vascularized tissue engineering constructs using microvascular free flaps as a novel tissue engineering strategy.</AbstractText>
</Abstract>
<Affiliation>Institute of Reconstructive Plastic Surgery, Laboratory of Vascular Tissue Engineering and Microvascular Research, New York University, New York, NY, USA. cetrulo4@hotmail.com</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cetrulo</LastName>
<ForeName>Curtis L</ForeName>
<Initials>CL</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Stem Cell Rev</MedlineTA>
<NlmUniqueID>101255952</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Lineage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fetal Blood</DescriptorName>
<QualifierName MajorTopicYN="Y">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mesenchymal Stem Cells</DescriptorName>
<QualifierName MajorTopicYN="Y">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neovascularization, Physiologic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Engineering</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
<QualifierName MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>55</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>1999</Year>
<Month>11</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>1999</Year>
<Month>11</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>1999</Year>
<Month>11</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>1</Month>
<Day>24</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>3</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pii">SCR:2:2:163</ArticleId>
<ArticleId IdType="pubmed">17237555</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>17237546</PMID>
<DateCreated>
<Year>2007</Year>
<Month>01</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>03</Month>
<Day>16</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1550-8943</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2006</Year>
</PubDate>
</JournalIssue>
<Title>Stem cell reviews</Title>
</Journal>
<ArticleTitle>Umbilical cord cells as a source of cardiovascular tissue engineering.</ArticleTitle>
<Pagination>
<MedlinePgn>87-92</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>There is increasing scientific evidence that human umbilical cord cells are a valuable source of adult stem cells that can be used for various implications including regenerative medicine and tissue engineering. The review describes the role of progenitor cells (mesenchymal, endothelial, prenatal) for the use in cardiovascular tissue engineering, i.e., the formation of large vessels and heart valves from umbilical cord cells. Currently used replacements in cardiovascular surgery are made of foreign materials with well known drawbacks such as thrombo-embolic complications, infection, loss of functional and biological properties, and others. Especially in the field of replacements in congenital cardiac defects, there would be a need of materials which have the advantage of optimal biological and mechanical properties. In the case of human umbilical cord cells, autologous cells can be used by minimally invasive procedures. The cells have excellent growth capacities and form a neo-matrix with excellent mechanical properties. For optimal growth and modeling, scaffolds are required with high biocompatibility and biodegradability, which allow cell attachment, ingrowth, and organization. Nutrients and waste must be easily transported and cells should be in entire contact with host's body. Finally, regenerated materials can be fully incorporated and the scaffold is completely replaced. Besides these cell and scaffold requirements, feto-maternal conditions and risk factors concerning deriving stem cells are of major interest. There are still many open questions concerning whether and how maternal conditions such as infection (viral or bacterial) or gestational age of the newborn influence stem cell harvesting and quality. If these cells will be used for the construction of replacement materials, it is clear that very strict criteria and protocols be introduced enabling the promising step from isolated cells to a therapeutic device such as a new heart valve. It is hoped that it will be only a question of time until human umbilical cord cells will be used frequently as the source of cardiovascular tissues among others in the clinical setting of treating congenital heart defects.</AbstractText>
</Abstract>
<Affiliation>Feto-Maternal Haematology Research Group, Obstetric Research, University Hospital Zurich. Christian.breymann@usz.ch</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Breymann</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schmidt</LastName>
<ForeName>Dörthe</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hoerstrup</LastName>
<ForeName>S P</ForeName>
<Initials>SP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Stem Cell Rev</MedlineTA>
<NlmUniqueID>101255952</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cardiovascular System</DescriptorName>
<QualifierName MajorTopicYN="Y">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Saphenous Vein</DescriptorName>
<QualifierName MajorTopicYN="N">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Engineering</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Umbilical Cord</DescriptorName>
<QualifierName MajorTopicYN="Y">cytology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>16</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>1999</Year>
<Month>11</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>1999</Year>
<Month>11</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>1999</Year>
<Month>11</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>1</Month>
<Day>24</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>3</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pii">SCR:2:2:87</ArticleId>
<ArticleId IdType="pubmed">17237546</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>17227284</PMID>
<DateCreated>
<Year>2007</Year>
<Month>01</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>02</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>03</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1470-8744</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>46</Volume>
<Issue>Pt 2</Issue>
<PubDate>
<Year>2007</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Biotechnology and applied biochemistry</Title>
<ISOAbbreviation>Biotechnol. Appl. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Biomaterials and scaffold design: key to tissue-engineering cartilage.</ArticleTitle>
<Pagination>
<MedlinePgn>73-84</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Cartilage remains one of the most challenging tissues to reconstruct or replace, owing to its complex geometry in facial structures and mechanical strength at articular surfaces in joints. This non-vascular tissue has poor replicative capacity and damage results in its functionally inferior repair tissue, fibrocartilage. This has led to a drive for advancements in tissue engineering. The variety of polymers and fabrication techniques available continues to expand. Pore size, porosity, biocompatibility, shape specificity, integration with native tissue, degradation tailored to rate of neocartilage formation and cost efficiency are important factors which need consideration in the development of a scaffold. The present review considers the current polymers and fabrication methodologies used in scaffold engineering for cartilage and postulates whether we are closer to developing the ideal scaffold for clinical application.</AbstractText>
</Abstract>
<Affiliation>Biomaterials and Tissue Engineering Centre, University Department of Surgery, University College London, Royal Free and University College Medical School, University College London, Rowland Hill Street, London NW3 2PF, UK.</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Raghunath</LastName>
<ForeName>Joanne</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rollo</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sales</LastName>
<ForeName>Kevin M</ForeName>
<Initials>KM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Butler</LastName>
<ForeName>Peter E</ForeName>
<Initials>PE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Seifalian</LastName>
<ForeName>Alexander M</ForeName>
<Initials>AM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Biotechnol Appl Biochem</MedlineTA>
<NlmUniqueID>8609465</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Biocompatible Materials</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biocompatible Materials</DescriptorName>
<QualifierName MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biomimetic Materials</DescriptorName>
<QualifierName MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cartilage</DescriptorName>
<QualifierName MajorTopicYN="Y">cytology</QualifierName>
<QualifierName MajorTopicYN="Y">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Culture Techniques</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chondrocytes</DescriptorName>
<QualifierName MajorTopicYN="N">cytology</QualifierName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Extracellular Matrix</DescriptorName>
<QualifierName MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Engineering</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>110</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>1</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pii">BA20060134</ArticleId>
<ArticleId IdType="doi">10.1042/BA20060134</ArticleId>
<ArticleId IdType="pubmed">17227284</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>17195462</PMID>
<DateCreated>
<Year>2007</Year>
<Month>01</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>01</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0724-6145</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>103</Volume>
<PubDate>
<Year>2007</Year>
</PubDate>
</JournalIssue>
<Title>Advances in biochemical engineering/biotechnology</Title>
<ISOAbbreviation>Adv. Biochem. Eng. Biotechnol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Perfusion effects and hydrodynamics.</ArticleTitle>
<Pagination>
<MedlinePgn>75-156</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Biological processes within living systems are significantly influenced by the motion of the liquids and gases to which those tissues are exposed. Accordingly, tissue engineers must not only understand hydrodynamic phenomena, but also appreciate the vital role of those phenomena in cellular and physiologic processes both in vitro and in vivo. In particular, understanding the fundamental principles of fluid flow underlying perfusion effects in the organ-level internal environment and their relation to the cellular microenvironment is essential to successfully mimicking tissue behavior. In this work, the major principles of hemodynamic flow and transport are summarized, to provide readers with a physical understanding of these important issues. In particular, since quantifying hemodynamic events through experiments can require expensive and invasive techniques, the benefits that can be derived from the use of computational fluid dynamics (CFD) packages and neural networking (NN) models are stressed. A capstone illustration based on analysis of the hemodynamics of aortic aneurysms is presented as a representative example of this approach, to stress the importance of tissue responses to flow-induced events.</AbstractText>
</Abstract>
<Affiliation>Department of Chemical Engineering, 102 Gleeson Hall, Oregon State University, Corvallis, OR 97331, USA. peattie@engr.orst.edu</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Peattie</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fisher</LastName>
<ForeName>Robert J</ForeName>
<Initials>RJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Adv Biochem Eng Biotechnol</MedlineTA>
<NlmUniqueID>8307733</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Flow Velocity</DescriptorName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Vessels</DescriptorName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Cell Physiology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Models, Cardiovascular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Perfusion</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulsatile Flow</DescriptorName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Engineering</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>104</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>1</Month>
<Day>2</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>1</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17195462</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>17173502</PMID>
<DateCreated>
<Year>2006</Year>
<Month>12</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>01</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1744-8344</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>4</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2006</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Expert review of cardiovascular therapy</Title>
</Journal>
<ArticleTitle>In search of a pediatric cardiac surgeon's 'Holy Grail': the ideal pulmonary conduit.</ArticleTitle>
<Pagination>
<MedlinePgn>861-70</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The limited lifespan of all currently available conduits leads to repeat operations and interventional procedures in many children. Each reoperation entails considerable risk to life, expenditure and compromised quality of life as the conduit degenerates. The ideal conduit should be available freely, inexpensive, require no anticoagulation, be resistant to infection, free from thromboembolism, have no gradients or regurgitation and have unlimited durability. This review explores various options as surgeons and researchers endeavor to develop the ideal conduit--which will fulfill all of the above-mentioned criteria. Various currently available conduits are analyzed. Special emphasis is given to tissue-engineered valves and percutaneous valve implantations.</AbstractText>
</Abstract>
<Affiliation>Apollo Hospital, Department of Cardiothoracic Surgery, 21 Greams Lane, Off Greams Road, Chennai-600006, India. nev_sheeba@yahoo.com</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Solomon</LastName>
<ForeName>Neville A G</ForeName>
<Initials>NA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pranav</LastName>
<ForeName>Subaraya K</ForeName>
<Initials>SK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Kailash A</ForeName>
<Initials>KA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Madhan</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kulkarni</LastName>
<ForeName>Chandrasekhar B</ForeName>
<Initials>CB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Akbari</LastName>
<ForeName>Jayesh</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Expert Rev Cardiovasc Ther</MedlineTA>
<NlmUniqueID>101182328</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bioprosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Defects, Congenital</DescriptorName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Valve Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">congenital</QualifierName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Heart Valve Prosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Ventricles</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulmonary Artery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Surgical Procedures, Minimally Invasive</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Engineering</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>56</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>12</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>1</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1586/14779072.4.6.861</ArticleId>
<ArticleId IdType="pubmed">17173502</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID>17150154</PMID>
<DateCreated>
<Year>2006</Year>
<Month>12</Month>
<Day>07</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1708-5381</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>14</Volume>
<Issue>6</Issue>
<PubDate>
<MedlineDate>2006 Nov-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Vascular</Title>
</Journal>
<ArticleTitle>Development of a tissue-engineered bypass graft seeded with stem cells.</ArticleTitle>
<Pagination>
<MedlinePgn>338-42</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The gold standard conduit for bypass of diseased small-diameter arteries remains autologous vascular tissue. In the absence of such tissue, patients are offered bypass with prosthetic material, with far less durable results. Vascular tissue engineering, the creation of a vascular conduit by seeding a tubular scaffold with various cells, may offer an alternative approach to this difficult situation. Herein we review some of the significant challenges that remain in designing an ideal vascular conduit and outline potential solutions offered by a graft created by seeding natural vascular tissue (decellularized vein allograft) with readily available autologous cells (adipose-derived stem cells).</AbstractText>
</Abstract>
<Affiliation>Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>DiMuzio</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fischer</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McIlhenny</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>DiMatteo</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Golesorhki</LastName>
<ForeName>Negar</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Grabo</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tarola</LastName>
<ForeName>Nicholas</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mericli</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shapiro</LastName>
<ForeName>Irving</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tulenko</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, N.I.H., Extramural</PublicationType>
<PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>Vascular</MedlineTA>
<NlmUniqueID>101196722</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>12</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>12</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17150154</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>16918275</PMID>
<DateCreated>
<Year>2006</Year>
<Month>08</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2006</Year>
<Month>10</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1744-8344</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>4</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2006</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Expert review of cardiovascular therapy</Title>
</Journal>
<ArticleTitle>Surgical treatment of coronary multivessel disease.</ArticleTitle>
<Pagination>
<MedlinePgn>569-81</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Coronary artery bypass grafting has had a significant impact on the treatment of angina, and has been the 'gold standard' since 1969. Its use and efficacy has been increased by revascularization in cardiac arrest and the use of the internal mammary artery. In parallel, catheter techniques have evolved by means of balloon dilatation and additional stenting. This has effected the referral to surgery despite the development of new arterialization techniques and minimally invasive surgery. As competing techniques, an acceptable equilibrium between surgery and stenting will be found within the next years.</AbstractText>
</Abstract>
<Affiliation>University Hopsital for Cardiac Surgery Salzburg, Müllner Hauptstrasse 48, 5020 Salzburg, Austria. o.stanger@salk.at</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stanger</LastName>
<ForeName>Olaf</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Unger</LastName>
<ForeName>Felix</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Expert Rev Cardiovasc Ther</MedlineTA>
<NlmUniqueID>101182328</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Angioplasty, Transluminal, Percutaneous Coronary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Clinical Competence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coronary Artery Bypass, Off-Pump</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coronary Disease</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coronary Vessels</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endarterectomy</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endoscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Internal Mammary-Coronary Artery Anastomosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Myocardial Revascularization</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radial Artery</DescriptorName>
<QualifierName MajorTopicYN="N">transplantation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Robotics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Surgical Procedures, Minimally Invasive</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Engineering</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue and Organ Harvesting</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vascular Patency</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Wound Healing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>155</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>8</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1586/14779072.4.4.569</ArticleId>
<ArticleId IdType="pubmed">16918275</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
</PubmedArticleSet>
|